Literature DB >> 7778688

Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue.

R B Nagle1, J Hao, J D Knox, B L Dalkin, V Clark, A E Cress.   

Abstract

The progression of prostate carcinoma may be influenced by the biochemical nature of the basal lamina surrounding the primary carcinoma cells. As a first step toward understanding this process, the composition and structure of the basal lamina in normal prostate, prostatic intraepithelial neoplasia, and human carcinoma were determined. In addition, a comparison was made between the attachments of the normal basal cell to its underlying basal lamina and those made by primary prostate carcinoma. The normal basal cells form both focal adhesions and hemidesmosomal-like structures as observed by transmission electron microscopy. The normal basal cells exhibited a polarized distribution of hemidesmosomal associated proteins including BP180, BP230, HD1, plectin, laminin-gamma 2(B2t), collagen VII, and the corresponding integrin laminin receptors alpha 6 beta 1 and alpha 6 beta 4. The expression and distribution pattern of these proteins were retained in the prostate intraepithelial neoplasia lesions. In contrast, the carcinoma cells uniformly lacked hemidesmosomal structures, the integrin alpha 6 beta 4, BP180, laminin-gamma 2 (B2t), and collagen VII but did express BP230 (30%), plectin, HD1 (15%), and the integrin laminin receptors alpha 3 beta 1 and alpha 6 beta 1. These results suggest that, although a detectable basal lamina structure is present in carcinoma, its composition and cellular attachments are abnormal. The loss of critical cellular attachments may play a role in influencing the progression potential of prostate carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778688      PMCID: PMC1870922     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes.

Authors:  P Verrando; B L Hsi; C J Yeh; A Pisani; N Serieys; J P Ortonne
Journal:  Exp Cell Res       Date:  1987-05       Impact factor: 3.905

2.  Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells.

Authors:  R B Nagle; W Böcker; J R Davis; H W Heid; M Kaufmann; D O Lucas; E D Jarasch
Journal:  J Histochem Cytochem       Date:  1986-07       Impact factor: 2.479

Review 3.  Structure and function of intercellular junctions.

Authors:  L A Staehelin
Journal:  Int Rev Cytol       Date:  1974

4.  Anchoring fibrils form a complex network in human and rabbit cornea.

Authors:  I K Gipson; S J Spurr-Michaud; A S Tisdale
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-02       Impact factor: 4.799

5.  The use of antikeratin antibodies in the diagnosis of human neoplasms.

Authors:  R B Nagle; K M McDaniel; V A Clark; C M Payne
Journal:  Am J Clin Pathol       Date:  1983-04       Impact factor: 2.493

6.  Basement membrane diversity detected by monoclonal antibodies.

Authors:  H Hessle; L Y Sakai; D W Hollister; R E Burgeson; E Engvall
Journal:  Differentiation       Date:  1984       Impact factor: 3.880

7.  Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.

Authors:  M E Hemler; F Sanchez-Madrid; T J Flotte; A M Krensky; S J Burakoff; A K Bhan; T A Springer; J L Strominger
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

8.  A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody.

Authors:  A Sonnenberg; H Janssen; F Hogervorst; J Calafat; J Hilgers
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

9.  Intraductal dysplasia: a premalignant lesion of the prostate.

Authors:  J E McNeal; D G Bostwick
Journal:  Hum Pathol       Date:  1986-01       Impact factor: 3.466

10.  Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells.

Authors:  M E Hemler; C F Ware; J L Strominger
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

View more
  52 in total

1.  Differential regulation of a novel variant of the alpha(6) integrin, alpha(6p).

Authors:  Tracy L Davis; Friederike Buerger; Anne E Cress
Journal:  Cell Growth Differ       Date:  2002-03

2.  Identification of a novel structural variant of the alpha 6 integrin.

Authors:  T L Davis; I Rabinovitz; B W Futscher; M Schnölzer; F Burger; Y Liu; M Kulesz-Martin; A E Cress
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

Review 3.  Integrin clipping: a novel adhesion switch?

Authors:  Manolis C Demetriou; Anne E Cress
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

4.  ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells.

Authors:  Justin M Drake; J Matthew Barnes; Joshua M Madsen; Frederick E Domann; Christopher S Stipp; Michael D Henry
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

5.  Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.

Authors:  P Dehan; D Waltregny; A Beschin; A Noel; V Castronovo; K Tryggvason; J De Leval; J M Foidart
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

6.  Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.

Authors:  Celeste L Kremer; Monika Schmelz; Anne E Cress
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

7.  Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.

Authors:  Michael O Ports; Ray B Nagle; Gerald D Pond; Anne E Cress
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

Review 8.  Integrins in prostate cancer progression.

Authors:  Hira Lal Goel; Jing Li; Sophia Kogan; Lucia R Languino
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

9.  Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization.

Authors:  Afshin Varzavand; Justin M Drake; Robert U Svensson; Mary E Herndon; Bo Zhou; Michael D Henry; Christopher S Stipp
Journal:  Clin Exp Metastasis       Date:  2012-12-06       Impact factor: 5.150

10.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.